Article Text

PDF
Levonorgestrel intra-uterine system for menorrhagia

Abstract

In 1996, we concluded that the levonorgestrel intra-uterine system (levonorgestrel IUS; Mirena - Schering Health Care) was an effective contraceptive.1 The product is now also licensed as a treatment for "idiopathic menorrhagia", with the claim that it "may be particularly useful in women with idiopathic menorrhagia requiring (reversible) contraception".2 We assess the efficacy and safety of levonorgestrel IUS in the management of heavy menstrual bleeding.

Statistics from Altmetric.com

  • Relevant BNF section: 7.3.2.3

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.